Groundbreaking test spares breast cancer patients from chemotherapy
A groundbreaking diagnostic test could spare millions of breast cancer patients worldwide from chemotherapy, experts say. Results from a new study suggest the test may redefine global treatment guidelines, allowing women to avoid the grueling side effects of cellgiftsbehandling—Swedish for chemotherapy—without compromising survival rates.
The test, details of which remain under embargo, identifies patients whose tumors are unlikely to respond to chemotherapy, enabling doctors to tailor treatment more precisely. "This could shift the paradigm for breast cancer care," said an oncologist involved in the research, as reported by *Svenska Dagbladet* . While the study’s full data has not yet been published, early indications point to a significant reduction in unnecessary chemotherapy for low-risk patients.
The development comes as separate trials reveal a potential breakthrough for patients resistant to conventional treatments. An experimental "triple-action" cancer jab has eradicated entire tumors in some patients whose disease had stopped responding to both chemotherapy and immunotherapy. In an international trial spanning 11 countries, the injection—still unnamed—triggered "unprecedented" responses, with tumors vanishing within weeks in a subset of participants, *The Guardian* reports . Romanian outlet *Digi24* echoed the findings, quoting doctors who described the results as "without precedent" for patients with limited therapeutic options .
Meanwhile, Mexico’s Ministry of Health has moved to reassure the public about the safety of chemotherapy drugs in its public healthcare system, following investigations by the *#CancerCalculus* initiative. The ministry stated that all medications meet "strict safety, quality, and efficacy standards," though it did not address specific allegations .
The advances in breast cancer diagnostics and late-stage treatment offer a stark contrast to the persistent challenges of chemotherapy resistance. While the new jab remains experimental, its success in patients who had exhausted all other options underscores the urgent need for alternatives to traditional chemotherapy. Regulatory approval and broader access to these innovations could take years, but oncologists describe the current momentum as a potential turning point in cancer care.
- der standard
- die zeit
- digi24
- svenska dagbladet
- elmundo
Articles
In response to the #CancerCalculus investigations findings, Mexicos Ministry of Health released a statement reassuring citizens that medications used in the public sector meet strict safety, quality, and efficacy standards. Learn more:
bluesky bot · 7 days ago
Kvinnor med bröstcancer kan slippa cellgifter Miljontals kvinnor med bröstcancer skulle kunna slippa cellgiftsbehandling tack vare ett banbrytande test. Detta enligt resultat från en studie som kan ge förändrade riktlinjer för cancervård världen, säger experter.
svenska dagbladet · 7 days ago
Kreuzfahrtschiff Hondius darf nach Hantavirus-Ausbruch weiterfahren Das Kreuzfahrtschiff wurde laut niederländischen Behörden nach dem tödlichen Hantavirus-Ausbruch erfolgreich gesäubert und desinfiziert
der standard · 7 days ago
Cancer jab can eradicate entire tumours in patients, trial shows Jab brought unprecedentedly strong responses in patients whose disease had become resistant to chemotherapy and immunotherapyDoctors have hailed unprecedented trial results that show a triple-action cancer jab can eradicate entire tumours in patients.In an international trial spanning 11 countries, the injection was offered to patients whose cancer had spread or come back and whose disease had failed to respond to other treatments. Continue reading...
theguardian · 7 days ago
EU receives experimental Hantavirus treatment from Japan The European Commission announced Thursday that 1,400 tablets of the experimental antiviral Favipiravir have arrived from Japan for potential use against Hantavirus infections in France, Spain, and the Netherlands, where the drug may be administered under compassionate use protocols.
yenisafak · 7 days ago
Cum funcționează injecţia care a eliminat complet tumorile la pacienţi la care chimioterapia nu dădea rezultate O injecţie experimentală împotriva cancerului a eliminat complet tumorile la unii pacienţi la care atât chimioterapia, cât şi imunoterapia nu mai funcţionau, potrivit rezultatelor unui studiu internaţional desfăşurat în 11 ţări. Medicii descriu răspunsul la tratament drept „fără precedent pentru această categorie de bolnavi, care au opţiuni terapeutice extrem de limitate, iar în cazul unora dintre participanţi tumorile au dispărut complet în doar câteva săptămâni.
digi24 · 7 days ago
Medizinische Selbstoptimierung: Wer stirbt, ist selbst schuld Der Körper ist für viele Menschen kein Schicksal mehr, sondern ein Projekt. Thailand setzt voll darauf – und positioniert sich als Weltzentrum der Selbstoptimierung.
die zeit · 7 days ago
Krebserkrankung: Star-Koch Johann Lafer: «Ich habe Lymphdrüsenkrebs»
die zeit · 7 days ago
Autorizan al crucero Hondius a volver a navegar tras ser desinfectado de Hantavirus Expertos en prevención de infecciones han determinado que el Hondius ha sido limpiado eficazmente tras el brote de Hantavirus Leer
elmundo · 7 days ago